SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 900.04 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 73.38 |
| Book Value / Share | 1.39 |
| Price / Book | n/a |
| NCAV ($M) | 57.93 |
| NCAV / Share | 1.09 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.15 |
| Return on Assets (ROA) | -0.87 |
| Return on Equity (ROE) | -1.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.37 |
| Current Ratio | 2.37 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 104.90 |
| Assets | 120.35 |
| Liabilities | 46.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.69 |
| Operating Income | -73.20 |
| Net Income | -85.78 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -47.50 |
| Cash from Investing | -17.56 |
| Cash from Financing | 54.03 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | LSP 7 Cooperative UA | 13.80 | 7.99 | |
| 13G/A | Bvcf Iv, L.p. | 5.05 | 5.88 | |
| 13G/A | Brunnur vaxtarsjodur slhf | 0.00 | -100.00 | |
| 13G | Pivotal bioVenture Partners Fund I, L.P. | 5.20 | 6.98 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,690 | 8,736 | 19.35 | |
| 2,687 | 63,478 | 4.23 | |
| 4,220 | 24,668 | 17.11 | |
| 1,123 | 6,661 | 16.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NGNE – Neurogene Inc. | NRIX – Nurix Therapeutics, Inc. |
| NTLA – Intellia Therapeutics, Inc. | OCUL – Ocular Therapeutix, Inc. |
| OKUR – OnKure Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io